PARK7 and cancer: High DJ-1 expression is linked to poor prognosis across numerous cancer types, including brain tumors, breast cancer, non-small cell lung carcinoma, prostate cancer, pancreatic carcinoma, hepatocellular carcinoma, and colorectal cancer.